Login / Signup

Persistent IDH mutations are not associated with increased relapse or death in patients with IDH-mutated acute myeloid leukemia undergoing allogeneic hematopoietic cell transplant with post-transplant cyclophosphamide.

Niveditha RavindraLaura W DillonGege GuiMatthew SmithLukasz P GondekRichard J JonesAdam CornerChristopher S HouriganAlexander J Ambinder
Published in: Bone marrow transplantation (2024)
Keyphrases